Kyle Y. Faget

GLP-1 Drugs: Brand Companies Push FDA To Limit Compounding

FDA Clinical Investigations: New Guidance On Electronic Systems

Cancer Drugs: Clinical Trial Issues For Antibody Drug Conjugates (ADCs)/Antibody Therapeutics

Medicare Coverage: CMS Finalizes New Pathway For Breakthrough Devices

Decentralized Clinical Trials: Research Misconduct Risks & How To Avoid Them

LDTs: FDA Rolls Out A Phased Implementation For New Regulatory Requirements

2024 Health Care & Life Sciences Top Trends - Driving Tomorrow's Advances In The Health Care And Life Sciences Ecosystems

FDA Continues To Take Stance That It Will Not Issue CBD Rules

New Favorable OIG Advisory Opinion Allows Patient Assistant Programs Funded By Drug Manufacturers

FDA: New Guidance For Non-interventional Studies Of Drug Safety And Effectiveness